NASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis $63.54 -0.48 (-0.75%) Closing price 03:59 PM EasternExtended Trading$63.18 -0.37 (-0.58%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Doximity Stock (NASDAQ:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Doximity alerts:Sign Up Key Stats Today's Range$62.69▼$64.0950-Day Range$55.92▼$66.7152-Week Range$34.34▼$85.21Volume818,945 shsAverage Volume2.36 million shsMarket Capitalization$11.94 billionP/E Ratio63.54Dividend YieldN/APrice Target$66.21Consensus RatingModerate Buy Company Overview Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. Read More Doximity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreDOCS MarketRank™: Doximity scored higher than 50% of companies evaluated by MarketBeat, and ranked 580th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingDoximity has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 10 buy ratings, 10 hold ratings, and no sell ratings.Amount of Analyst CoverageDoximity has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.08% Earnings GrowthEarnings for Doximity are expected to grow by 8.08% in the coming year, from $0.99 to $1.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 62.93, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.51.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 62.93, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.18.Price to Earnings Growth RatioDoximity has a PEG Ratio of 4.10. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 11.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for DOCS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for DOCS. News and Social Media2.7 / 5News Sentiment0.80 News SentimentDoximity has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 45 news articles for Doximity this week, compared to 14 articles on an average week.Search InterestOnly 13 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.MarketBeat Follows9 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,140,940.00 in company stock.Percentage Held by Insiders31.30% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesDOCS- A Healthcare Play That's on the Move After Beat-and-Raise QuarterAugust 14 at 9:54 AM | finance.yahoo.comDoximity’s Q2 Earnings Call: Our Top 5 Analyst QuestionsAugust 14 at 9:54 AM | msn.comWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.August 14 at 2:00 AM | Porter & Company (Ad)Doximity’s Earnings Call Highlights Growth and AI AdvancesAugust 13 at 4:36 AM | msn.comDoximity (NASDAQ:DOCS) Stock Price Expected to Rise, Piper Sandler Analyst SaysAugust 13 at 2:27 AM | americanbankingnews.comDoximity (NASDAQ:DOCS) Trading Down 6.5% Following Insider SellingAugust 13 at 2:38 AM | americanbankingnews.comDOCS Q2 Deep Dive: AI Investment, Product Expansion, and Broad-Based Customer MomentumAugust 12 at 6:34 PM | finance.yahoo.comBrokerages Set Doximity, Inc. (NASDAQ:DOCS) Target Price at $66.68August 12 at 2:21 AM | americanbankingnews.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $53.39 at the beginning of 2025. Since then, DOCS stock has increased by 17.9% and is now trading at $62.9350. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) issued its quarterly earnings data on Thursday, August, 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. The firm's revenue was up 15.2% compared to the same quarter last year. When did Doximity IPO? Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional shareholders include William Blair Investment Management LLC (2.78%), State Street Corp (2.15%), Geode Capital Management LLC (1.94%) and Franklin Resources Inc. (1.68%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Regina M Benjamin, Kira Scherer Wampler, Watkin Phoebe L Yang and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Doximity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ). Company Calendar Last Earnings8/07/2025Today8/14/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryComputer Software Current SymbolNASDAQ:DOCS CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees890Year FoundedN/APrice Target and Rating Average Price Target for Doximity$66.21 High Price Target$90.00 Low Price Target$50.00 Potential Upside/Downside+4.2%Consensus RatingModerate Buy Rating Score (0-4)2.64 Research Coverage22 Analysts Profitability EPS (Trailing Twelve Months)$1.17 Trailing P/E Ratio63.54 Forward P/E Ratio64.18 P/E Growth4.1Net Income$147.58 million Net Margins36.60% Pretax Margin46.01% Return on Equity21.75% Return on Assets18.64% Debt Debt-to-Equity RatioN/A Current Ratio8.74 Quick Ratio8.74 Sales & Book Value Annual Sales$589.64 million Price / Sales20.24 Cash Flow$0.78 per share Price / Cash Flow81.32 Book Value$5.52 per share Price / Book11.51Miscellaneous Outstanding Shares187,826,000Free Float116,869,000Market Cap$11.94 billion OptionableNot Optionable Beta1.36 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:DOCS) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.